David Ryan Bakal

David Bakal practices at UCSD Hillcrest Medical Center in San Diego, California.

David Bakal's NPI, 1023513983, was assigned on March 23, 2018. David Bakal graduated from David Geffen School of Medicine at UCLA in 2018. David Bakal's California license number on file is A164553.

David Bakal's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

David Bakal's primary practice is UCSD Hillcrest Medical Center in San Diego, California. David Bakal is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links David Bakal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Bakal practices, 2 sites in all. Vendor and product names are available with a free account.

Physical medicine and rehabilitation is David Bakal's primary specialty in the NPI Registry, under taxonomy code 208100000X. David Bakal is board certified in sports medicine by the American Board of Emergency Medicine. Dmand AI has David Bakal's licenses on file in 2 states: California and Georgia.

Dmand AI lists arthritis, joint pain, muscle pain, fibromyalgia, and limb pain, rotator cuff injury and thoracic spine disorders among the conditions David Bakal treats.

CMS data shows 1,778 Medicare services from David Bakal across 9 procedure codes in 2024, for 322 Medicare patients. Medicare paid $68,077 for them.

CMS counts 322 Medicare patients who saw David Bakal in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have arthritis, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts David Bakal's median patient age at 60, with 58% women.

In 2024, David Bakal wrote 37 Medicare Part D claims for 20 patients. 100% of them were for generic drugs. CMS names the drug for 29 of them, across 1 drug with 11 or more claims each, at $561 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for David Bakal for performance year 2024, reported as part of a group. David Bakal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David Bakal as offering telehealth.

Dmand AI links 5 papers to David Bakal, published from 2022 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Athletic Injuries, Athletes and Soccer. David Bakal has published most often in PM R. David Bakal's most frequent co-authors are Jennifer Lynn Carlson, MD, Paige McCall Dyrek, DO and Michael Fredericson, MD.

CMS Open Payments shows 5 general payments to David Bakal from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Bioventus LLC paid the most, $144.

David Bakal graduated from David Geffen School of Medicine at UCLA in 2018.

David Bakal is in network with 13 carriers, including United Healthcare, Elevance and Aetna. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.